Fluticasone + SalmeterolThird Party Manufacturing in India

Fluticasone + Salmeterol works by combining a potent anti-inflammatory glucocorticoid with a long-acting bronchodilator to address both inflammation and bronchoconstriction simultaneously. Fluticasone propionate binds to glucocorticoid receptors to reduce airway inflammation and mucus production, while salmeterol xinafoate stimulates beta2-receptors to maintain smooth muscle relaxation for up to twelve hours. Unlike quick-relief inhalers, it provides long-term control over chronic airway hypersensitivity. It is highly effective and well-tolerated for maintenance therapy. Securing Fluticasone + Salmeterol third party manufacturing in India helps brands capture a vast maintenance-therapy market share. The primary steroid component is authenticated globally via CAS number 80474-14-2.

Therapeutic Uses

• Asthma Management: Used for the regular maintenance treatment of asthma where a combination product is appropriate.
• COPD Control: Reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease.

Why Manufacturers Choose Fluticasone + Salmeterol

Celesta Healthcare streamlines sourcing by vetting top-tier aerosol plants across the country. Our partner facilities are WHO-GMP certified, delivering superior formulation stability and exact dosing accuracy. Partnering with a reliable Fluticasone + Salmeterol third party manufacturer in India ensures a steady commercial supply chain.